KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Fulgent Genetics (FLGT) over the last 10 years, with Q3 2025 value amounting to $9.7 million.

  • Fulgent Genetics' Share-based Compensation fell 1101.65% to $9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.7 million, marking a year-over-year decrease of 1052.85%. This contributed to the annual value of $44.5 million for FY2024, which is 363.22% up from last year.
  • Per Fulgent Genetics' latest filing, its Share-based Compensation stood at $9.7 million for Q3 2025, which was down 1101.65% from $10.0 million recorded in Q2 2025.
  • Fulgent Genetics' 5-year Share-based Compensation high stood at $11.6 million for Q2 2024, and its period low was $3.0 million during Q1 2021.
  • Its 5-year average for Share-based Compensation is $8.7 million, with a median of $10.0 million in 2025.
  • In the last 5 years, Fulgent Genetics' Share-based Compensation soared by 22648.15% in 2021 and then tumbled by 1371.72% in 2025.
  • Fulgent Genetics' Share-based Compensation (Quarter) stood at $5.0 million in 2021, then soared by 99.64% to $10.0 million in 2022, then increased by 14.07% to $11.4 million in 2023, then fell by 8.96% to $10.4 million in 2024, then decreased by 6.64% to $9.7 million in 2025.
  • Its Share-based Compensation was $9.7 million in Q3 2025, compared to $10.0 million in Q2 2025 and $10.5 million in Q1 2025.